Franz Hefti
Chief Executive Officer at PREVAIL THERAPEUTICS INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stella Sarraf | M | - |
Spinogenix, Inc.
 Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA. | 8 years |
| Cynthia Lavoie | M | - |
FAAH Pharma, Inc.
 FAAH Pharma, Inc. BiotechnologyHealth Technology FAAH Pharma, Inc. operates as a project-focused company developing a clinical asset initially for postherpetic neuralgia. The company was founded on June 26, 2014 and is headquartered in Montreal, Canada. | 10 years |
| Patricia Russo | F | 71 | 29 years | |
| Peter Barrett | M | 71 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Vincent Simmon | M | - |
Spinogenix, Inc.
Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA. | - |
| Mark A. Mintun | M | - |
Avid Radiopharmaceuticals, Inc.
 Avid Radiopharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avid Radiopharmaceuticals, Inc. provides molecular imaging services. It develops new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies. The company was founded by Daniel M. Skovronsky in 2004 and is headquartered in Philadelphia, PA. | 14 years |
| Mark McDade | M | 69 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Gosse Bote Bruinsma | M | 69 |
FAAH Pharma, Inc.
FAAH Pharma, Inc. BiotechnologyHealth Technology FAAH Pharma, Inc. operates as a project-focused company developing a clinical asset initially for postherpetic neuralgia. The company was founded on June 26, 2014 and is headquartered in Montreal, Canada. | - |
| Mervyn Turner | M | 77 |
Spinogenix, Inc.
Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA. | - |
| Gail Farfel | M | 60 |
FAAH Pharma, Inc.
FAAH Pharma, Inc. BiotechnologyHealth Technology FAAH Pharma, Inc. operates as a project-focused company developing a clinical asset initially for postherpetic neuralgia. The company was founded on June 26, 2014 and is headquartered in Montreal, Canada. | - |
| Jeffrey Sevigny | M | 55 | 6 years | |
| Anderson Timothy | M | - |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Yong Dai | M | 53 | 5 years | |
| Emily Minkow | F | 41 | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert P. Luciano | M | - | 23 years | |
| Jonathan Solomon | M | 47 |
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | 9 years |
| Francois Nader | M | 67 | 3 years | |
| Raymond Gilmartin | M | 82 | 2 years | |
| G. Kirk Raab | M | 88 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| Suzanne Bruhn | M | 60 |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | 1 years |
| Thomas Shenk | M | 77 | 11 years | |
| Ran Nussbaum | M | 51 | 3 years | |
| Arthur Levinson | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 19 years |
| Joseph Romanelli | M | 50 | 19 years | |
| Anne Tatlock | F | 84 | - | |
| William Harrison | M | 80 | - | |
| Wendy Yarno | F | 69 | 9 years | |
| David Nagler | M | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Morgan Sheng | M | - | 2 years | |
| Larry G. Edwards | M | 52 | 15 years | |
| Peter Thompson | M | 64 | 4 years | |
| Marino Carol | F | - | 8 years | |
| David Gionco | M | 63 | 3 years | |
| Laura Sepp-Lorenzino | M | 63 | 15 years | |
| Tim Adams | M | 64 | 2 years | |
| Silvana Battaglia | F | 56 | 10 years | |
| Joe Pedersen | M | - | 23 years | |
| Christine Bunt | F | - | 7 years | |
| David A. Esposito | M | 55 | 13 years | |
| James Villalobos | M | 55 | - | |
| Dorothy P. Bowers | F | - | - | |
| Robert W. Verdugo | M | - | 3 years | |
| Peter Honig | M | 67 | 7 years | |
| Michael Atieh | M | 70 | 19 years | |
| Wei Tang | M | - | 15 years | |
| Eric Schadt | M | 59 | 8 years | |
| Amit Hasija | M | 51 | 5 years | |
| Soren Christiansen | M | 68 | 19 years | |
| Edward Berg | M | - | 8 years | |
| Tom Caskey | M | - | 6 years | |
| John Renger | M | 55 | 15 years | |
| Katherine Beebe-DeVarney | M | 63 | 2 years | |
| Kimberly Murphy | F | 62 | 6 years | |
| Jens Renstrup | M | 59 | 8 years | |
| Karen Quintos | F | 60 | 4 years | |
| Ernesto Aycardi | M | 61 | 11 years | |
| Juan Camilo Arjona Ferreira | M | 54 | 12 years | |
| Desiree Ralls-Morrison | F | 57 | 8 years | |
| Jacob Harel | M | 69 | 13 years | |
| Valerie Sharice Grant | F | - | 2 years | |
| Glenn Williams | M | - | 10 years | |
| Kathleen Metters | M | 66 | 13 years | |
| Bobby Dwayne Montgomery | M | 56 | 5 years | |
| Ed M. Scolnick | M | 83 | 20 years | |
| Jim Hinrichs | M | 56 | 5 years | |
| David Arkowitz | M | 62 | 3 years | |
| John L. Zabriskie | M | 85 | 6 years | |
| Heidi Miller | M | 70 | 4 years | |
| Barry Gumbiner | M | 68 | 6 years | |
| Tassos Gianakakos | M | 51 | 2 years | |
| Mark E. McDonough | M | 59 | - | |
| Ronald Newbold | M | 61 | 9 years | |
| Peter G. Ernster | M | 82 | 26 years | |
| Margaret McGlynn | F | 64 | 11 years | |
| Joan Wainwright | F | 63 | 6 years | |
| Marcia Avedon | M | 62 | 4 years | |
| J. Carroll | M | 74 | 25 years | |
| Simon Benito | M | 79 | 25 years | |
| Paul Howes | M | 69 | 5 years | |
| Adel Mahmoud | M | 82 | 7 years | |
| Robert G. Johnson | M | 72 | 7 years | |
| Gerald McLaughlin | M | 56 | 11 years | |
| Paul M. Mendelman | M | 76 | 5 years | |
| Linda Burns | F | - | 1 years | |
| Misti Ushio | M | 53 | 10 years | |
| Penny M. Heaton | M | 59 | 7 years | |
| Thomas J. Ouellette | M | - | 16 years | |
| Gerald J. Gallivan | M | - | - | |
| Paul Ronald Bell | M | 76 | 14 years | |
| Elizabeth Hamilton Seabury Wyatt | M | 76 | 20 years | |
| Frank Verwiel | M | 62 | 4 years | |
| Vijay Samant | M | 77 | 23 years | |
| Alan Sachs | M | - | - | |
| Alan Nies | M | 86 | 10 years | |
| William G. Roberts | M | 66 | 6 years | |
| N. Coles | M | 63 | 4 years | |
| David S. Doll | M | - | 8 years | |
| William Daley | M | 75 | 4 years | |
| Jeffrey A. Peris | M | 77 | 25 years | |
| Sean Dobson | M | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 97 | 97.00% |
| Canada | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Franz Hefti
- Personal Network
